An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…

immunotherapy

Chutes & Ladders: J&J vet Bridget Ross jumps ship to Henry Schein

GeoVax draws a bead on hep B with therapeutic vaccine deal

Scientists explore new ideas for improving cancer immunotherapy

Cancer therapies were trialed most among CROs in Q3: Report

Targeting both immune system branches could be key for cancer immunotherapy

Roche highlights I/O combos as it drops solo development of vanucizumab

CAR-T cells can be effective protein delivery vehicles to treat lymphoma

U.K. cancer charity, investment firm launch neoantigen biotech

AbbVie partners with Karolinska immunotherapy startup in Parkinson’s

Hybrid nanovaccine tackles cancer immunotherapy challenges in mice